#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Loeys-Dietz syndrome Cytokine release syndrome Krabbe's disease Hyperoxaluria Juvenile idiopathic arthritis Spinal cord injury cervical Systemic scleroderma Osteomyelitis Acute lymphocytic leukaemia Phaeochromocytoma Hepatic cirrhosis Osteosarcoma metastatic Andersen-Tawil syndrome Adenovirus infection Asthma More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Basic Information Uterine leiomyosarcoma – Trials in Disease KBG syndrome – Diagnostics Osteosarcoma Mucopolysaccharidosis I – Life with Disease Factor IX deficiency Congenital hypotransferrinaemia – Life with Disease Lymphangioma – Life with Disease Idiopathic inflammatory myopathy – Life with Disease Hereditary optic atrophy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000070248 ORX750 Zinc Sulphate Heptahydrate ULEFNERSEN Rondaptivon Pegol Bictegravir 64Cu-Dota-Ae105 Clioquinol VELPATASVIR Bleomycin Sulfate Ph. Eur. Mva-209-Fsp-B3 Technetium (99Mtc) Ciclesonide Rifabutin Trazodone Dacomitinib Alectinib Hydrochloride Bevacizumab Human Plasma Protein Valproate Semisodium More therapies…

    Learn about Your Condition

    Hyperinsulinism Laparotomy Aneurysm ruptured Cutaneous T-cell lymphoma Cardiac valve disease Cholestatic pruritus Brain neoplasm Gastrooesophageal cancer Anal abscess Large cell lung cancer stage 0 Malignant glioma Colon cancer metastatic Influenza Familial mediterranean fever Hypoxia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Spironolactone for Patients with Arrhythmogenic Right Ventricular Dysplasia (ARVD)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Arrhythmogenic right ventricular dysplasia
    Investigated Drugs:
    • Spironolactone
    France

  • Study of Tenofovir Alafenamide for Children and Teens with Chronic Hepatitis B

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Tenofovir Alafenamide
    Romania

  • Study on the Effects of XTMAB-16 and Prednisolone in Patients with Pulmonary Sarcoidosis with or without Other Body Involvement

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Sarcoidosis
    Investigated Drugs:
    • Prednisolone Sodium Phosphate
    • Xtmab-16
    • Prednisolone
    Czechia Denmark Greece Italy Poland Spain

  • Study on Durvalumab with Chemotherapy for Patients with Advanced Biliary Tract Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Biliary tract disorder
    Investigated Drugs:
    • Durvalumab
    • Carboplatin
    • Cisplatin
    France Germany Italy Spain

  • Study of ipatasertib with atezolizumab and chemotherapy in women with triple-negative breast cancer before surgery

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Ipatasertib
    • Atezolizumab
    Germany Spain

  • Study on Empagliflozin for Patients with Non-Alcoholic Steatohepatitis (NASH)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Investigated Drugs:
    • Empagliflozin
    Czechia
Previous Page
1 … 899 900 901 902 903 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!